Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma
about
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review.The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.Positron Emission Tomography in Mucosal Melanomas of Head and Neck: Results from a South Asian Tertiary Cancer Care Center
P2860
Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@ast
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@en
type
label
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@ast
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@en
prefLabel
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@ast
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@en
P2093
P2860
P1433
P1476
Metabolic response by FDG-PET ...... patients with mucosal melanoma
@en
P2093
Anita Giobbie-Hurder
Annick D Van den Abbeele
F Stephen Hodi
Jeffrey Weber
Katherine Zukotynski
Rene Gonzalez
Steven O'Day
Thomas F Gajewski
P2860
P2888
P356
10.1186/S40644-014-0030-0
P50
P577
2014-11-12T00:00:00Z
P5875
P6179
1046307727